Medical & Procedural Options

Name: Medical & Procedural Options
Brand: Boling Vision Center

For guests whose dry eye and ocular surface disease require more than drops and at-home care, Boling Vision Center's Cornea & Ocular Surface Center offers a full range of medical and procedural treatment options designed to address the condition at its source.

Beyond the Eye Drop Aisle: When Dry Eye Needs More

Artificial tears have their place, but for many guests with moderate to severe dry eye disease, they're simply not enough. When the underlying drivers of dry eye, whether inflammation, meibomian gland dysfunction, tear deficiency, or lid margin disease, are left unaddressed, symptoms persist regardless of how many drops are used throughout the day.

At Boling Vision Center, we offer the medical and procedural treatments that get to the root of the problem, matched to each guest's specific diagnosis and tailored to their individual needs. Schedule a comprehensive dry eye evaluation at any of our four Northern Indiana locations and find out which medical and procedural options are right for your situation.

How We Determine the Right Treatment

Effective dry eye treatment begins with accurate diagnosis. Before recommending any medical or procedural intervention, our team conducts a thorough evaluation using advanced diagnostic tools to characterize exactly what's driving the condition.

That evaluation includes tear film analysis, meibomian gland imaging, ocular surface staining, and a detailed slit-lamp examination of the lid margins, conjunctiva, and cornea. The findings guide every treatment recommendation, ensuring that what we prescribe is matched to the mechanisms actually present rather than a generic protocol applied to everyone with dry eye symptoms.

Medical Treatment Options

Medical treatments for dry eye target the underlying disease processes driving tear film instability and ocular surface breakdown.

Prescription Anti-Inflammatory Therapy

For many guests, chronic ocular surface inflammation is the central driver of their dry eye disease. Prescription anti-inflammatory eye drops, including cyclosporine and lifitegrast formulations, interrupt the inflammatory cycle at the cellular level, helping to restore healthier surface cell function and improve tear quality over time.

These medications are designed for long-term use and build their full benefit gradually over one to three months of consistent treatment. They are among the most evidence-backed options available for chronic dry eye disease.

Topical Corticosteroids

For acute inflammatory flares or as a short-term bridge while longer-acting therapies establish their effect, topical corticosteroid drops can provide rapid relief. Because of their side effect profile with prolonged use, they are prescribed for defined short courses and monitored carefully.

Autologous Serum Eye Drops

Prepared from the guest's own blood, autologous serum drops contain growth factors, vitamins, and proteins that closely mimic the composition of natural tears and actively support ocular surface healing. They are reserved for guests with severe dry eye that hasn't responded adequately to conventional therapies, including those with neurotrophic dry eye or ocular surface disease associated with autoimmune conditions.

Oral Medications

For some guests, particularly those with ocular rosacea or significant meibomian gland dysfunction, oral medications with anti-inflammatory properties can be an effective adjunct to topical treatment. Low-dose doxycycline, for example, has well-established effects on meibomian gland secretion quality and lid margin inflammation that make it a useful component of a comprehensive treatment plan in the right candidates.

Nutritional Supplementation

Omega-3 fatty acid supplementation has meaningful clinical evidence supporting its role in improving meibomian gland secretion quality and reducing ocular surface inflammation. We discuss nutritional support as part of the medical treatment conversation for guests where it's appropriate, recognizing that what happens systemically affects what happens at the ocular surface.

Schedule A Consultation

Very friendly, professional staff. Prompt, waited less than 5 minutes for my appointment. Dr. Boling was professional, cordial, and informative.

Denise Tiller

Procedural Treatment Options

For conditions that don't respond adequately to medical therapy alone, in-office procedures address the structural and functional drivers of dry eye disease more directly.

Meibomian Gland Treatment (iLux)

iLux delivers controlled heat and compression to the eyelids, clearing blocked meibomian glands and restoring the lipid layer of the tear film. It is one of our primary tools for treating evaporative dry eye driven by MGD, producing improvements in gland function that no topical therapy can replicate. For guests with significant gland blockage, iLux is often among the most impactful single interventions in their treatment plan.

Intense Pulsed Light (IPL) Therapy

IPL uses precisely calibrated pulses of light to target the abnormal blood vessels around the eyelid margins that contribute to meibomian gland inflammation and dysfunction. It reduces the inflammatory mediators driving evaporative dry eye and is particularly valuable for guests with ocular rosacea or significant lid margin vascular disease. IPL is delivered as a series of in-office sessions and is well tolerated by most guests.

BlephEx Eyelid Cleaning

BlephEx uses a precisely controlled micro-rotating sponge to remove the bacterial biofilm, Demodex debris, and accumulated lid margin deposits that drive chronic blepharitis and contribute to meibomian gland dysfunction. It addresses the lid margin environment at a level of thoroughness that at-home hygiene measures cannot achieve.

Punctal Occlusion

For guests with aqueous-deficient dry eye, punctal occlusion reduces tear drainage by closing the small openings in the inner corner of each eyelid, retaining more of the tears being produced on the ocular surface. It can be performed temporarily with dissolvable plugs to assess response, or with semi-permanent silicone plugs for guests who respond well. The procedure is simple, well-tolerated, and can provide meaningful relief as part of a broader treatment plan.

Celluma Low-Level Light Therapy

Celluma delivers therapeutic wavelengths of light to the periocular tissue, reducing inflammation, supporting meibomian gland function, and promoting ocular surface healing at the cellular level. It is a gentle, non-invasive option that complements other medical and procedural treatments and is well-suited for guests who prefer to minimize pharmacologic interventions.

Amniotic Membrane Therapy

For guests with significant ocular surface breakdown, persistent epithelial defects, or severe inflammation that hasn't responded to other treatments, amniotic membrane therapy provides a biological scaffold with potent anti-inflammatory and healing-promoting properties. It can be applied in the office as a self-retained treatment and is one of the more advanced tools in our ocular surface care toolkit.

Scleral Lens Fitting

For guests with moderate to severe dry eye, particularly those with irregular corneal surfaces or tear film instability that can't be adequately addressed through other means, scleral lenses provide continuous hydration and optical correction by creating a fluid reservoir over the entire corneal surface. They are a transformative option for the right candidate and are fitted and managed through our cornea and ocular surface team.

Combining Medical and Procedural Care

Dry eye disease is rarely driven by a single factor, and the most effective treatment plans address multiple mechanisms simultaneously. At Boling Vision Center, medical and procedural options are combined thoughtfully based on each guest's diagnostic profile, with the plan evolving as the ocular surface responds and heals.

Regular follow-up is an important part of that process. We track objective markers of ocular surface health alongside symptom improvement, adjusting the plan as needed to ensure treatment continues to be matched to where things stand.

Why Choose Boling Vision Center?

Boling Vision Center's Cornea & Ocular Surface Center offers the full spectrum of medical and procedural dry eye treatments, advanced diagnostics, and the clinical expertise to know which combination is right for each guest. We don't apply the same protocol to everyone; we evaluate thoroughly, treat specifically, and stay engaged through the long term.

With four Northern Indiana locations and a team that takes dry eye seriously as the medical condition it is, we're the practice guests with complex or persistent dry eye trust to get it right. Amazing happens here.

doctor treating a patient | glasses on racks | abstract art

Frequently Asked Questions Medical & Procedural Options

How do I know whether I need medical treatment, a procedure, or both?

That determination comes from a thorough evaluation. The drivers of dry eye vary significantly between guests, and the appropriate treatment follows directly from what the evaluation finds. Some guests need primarily medical management; others benefit most from procedural intervention; many need a combination of both. There's no way to answer that question accurately without a proper diagnostic workup.

Are these treatments covered by insurance?

Coverage varies significantly depending on the treatment and the insurance plan. Prescription medications are often covered with prior authorization. Some procedural treatments, like punctal occlusion, may be covered when medically indicated. Others, including IPL and BlephEx, are frequently considered elective. Our team will help you understand your coverage situation and discuss the investment involved in any recommended treatment before you proceed.

How long will I need to continue medical treatment?

Dry eye disease is often chronic, meaning ongoing management is typically needed to sustain improvement. That said, the intensity of treatment often decreases over time as the ocular surface stabilizes. Many guests transition to a simpler maintenance regimen after an initial period of more active treatment. Your provider will guide that process based on how your ocular surface responds.

What if I've already tried prescription drops and they didn't help?

Prescription drops are effective for many guests but aren't the right answer for everyone, and they work best when inflammation is the primary driver of the condition. If drops haven't helped, it's worth evaluating whether other mechanisms, such as meibomian gland dysfunction, lid margin disease, or structural factors, are playing a larger role. A fresh, comprehensive evaluation often reveals factors that weren't fully addressed in prior treatment, and procedural options may offer improvement where medical therapy alone has fallen short.

Can I receive these treatments if my dry eye was caused by prior surgery?

Yes. Post-surgical dry eye is one of the conditions we commonly manage, and the medical and procedural options available are largely the same regardless of the underlying cause. The evaluation will characterize what's driving your specific post-surgical dry eye, and treatment will be tailored accordingly.